Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1958 1
1959 1
1961 1
1962 6
1963 4
1964 7
1965 5
1966 4
1967 7
1968 13
1969 4
1970 10
1971 5
1972 1
1973 5
1974 12
1975 9
1976 16
1977 8
1978 13
1979 15
1980 7
1981 10
1982 25
1983 23
1984 22
1985 25
1986 39
1987 33
1988 24
1989 42
1990 31
1991 37
1992 38
1993 36
1994 59
1995 48
1996 48
1997 61
1998 51
1999 49
2000 46
2001 52
2002 50
2003 67
2004 65
2005 97
2006 97
2007 92
2008 92
2009 123
2010 134
2011 142
2012 142
2013 164
2014 150
2015 180
2016 176
2017 188
2018 158
2019 149
2020 146
2021 171
2022 168
2023 155
2024 177
2025 181
2026 77

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,879 results

Results by year

Filters applied: . Clear all
Page 1
Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial.
Budde LE, Zhang H, Kim WS, Maruyama D, Rego EM, Norasetthada L, Hong H, Ozcan M, Jeon YW, Leão Cordeiro de Farias D, Fogliatto LM, Pavlovsky A, Goto H, Olszewski AJ, Shah N, Hu B, Yin S, Wu H, To I, Ead WS, Ashby J, Janousek M, Pham S, Wang J, Kwan A, Batlevi CL, Wei MC, Westin J. Budde LE, et al. Among authors: goto h. J Clin Oncol. 2025 Dec 20;43(36):3799-3811. doi: 10.1200/JCO-25-01957. Epub 2025 Oct 2. J Clin Oncol. 2025. PMID: 41037766 Free PMC article. Clinical Trial.
Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study.
Morschhauser F, Dahiya S, Palomba ML, Martin Garcia-Sancho A, Reguera Ortega JL, Kuruvilla J, Jäger U, Cartron G, Izutsu K, Dreyling M, Kahl B, Ghesquieres H, Ardeshna K, Goto H, Barbui AM, Abramson JS, Borchmann P, Fleury I, Mielke S, Skarbnik A, de Vos S, Kamdar M, Karmali R, Viardot A, Farazi T, Fasan O, Lymp J, Vedal M, Nishii R, Avilion A, Papuga J, Kumar J, Nastoupil LJ. Morschhauser F, et al. Among authors: goto h. Nat Med. 2024 Aug;30(8):2199-2207. doi: 10.1038/s41591-024-02986-9. Epub 2024 Jun 3. Nat Med. 2024. PMID: 38830991 Free PMC article. Clinical Trial.
Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial.
Song Y, Tilly H, Rai S, Zhang H, Jin J, Goto H, Terui Y, Shin HJ, Kim WS, Cao J, Feng J, Eom HS, Kim TM, Tsai XC, Gau JP, Koh H, Zhang L, Song Y, Yang Y, Li W, Huang H, Ando K, Sharman JP, Sehn LH, Bu L, Wang X, Jiang Y, Hirata J, Lee C, Zhu J, Izutsu K. Song Y, et al. Among authors: goto h. Blood. 2023 Apr 20;141(16):1971-1981. doi: 10.1182/blood.2022017734. Blood. 2023. PMID: 36626583 Free PMC article. Clinical Trial.
Application of Metagenomic Long-Read Sequencing for the Diagnosis of Herpetic Uveitis.
Koyanagi Y, Sajiki AF, Yuki K, Ushida H, Kawano K, Fujita K, Shimizu H, Okuda D, Kosaka M, Yamada K, Suzumura A, Kachi S, Kaneko H, Komatsu H, Usui Y, Goto H, Nishiguchi KM. Koyanagi Y, et al. Among authors: goto h. Invest Ophthalmol Vis Sci. 2025 Apr 1;66(4):50. doi: 10.1167/iovs.66.4.50. Invest Ophthalmol Vis Sci. 2025. PMID: 40244604 Free PMC article.
Multidisciplinary treatment for advanced gastric cancer.
Kanaji S, Urakawa N, Harada H, Ikeda T, Koterazawa Y, Aoki T, Sawada R, Otowa Y, Goto H, Hasegawa H, Yamashita K, Matsuda T, Kakeji Y. Kanaji S, et al. Among authors: goto h. Int J Clin Oncol. 2025 Jul;30(7):1268-1275. doi: 10.1007/s10147-025-02792-4. Epub 2025 May 29. Int J Clin Oncol. 2025. PMID: 40439973 Review.
The Tumor Immune Microenvironment and Therapeutic Efficacy of Trastuzumab Deruxtecan in Gastric Cancer.
Koganemaru S, Koyama S, Suto F, Koga M, Inaki K, Kuwahara Y, Arita T, Hirata T, Goto H, Wada N, Kobayashi M, Shibutani T, Okabayashi T, Nakamaru K, Kawazoe A, Togashi Y, Nishikawa H, Shitara K. Koganemaru S, et al. Among authors: goto h. Cancer Res Commun. 2025 Jan 1;5(1):84-93. doi: 10.1158/2767-9764.CRC-24-0302. Cancer Res Commun. 2025. PMID: 39679910 Free PMC article.
Multi-omics analysis identifies an M-MDSC-like immunosuppressive phenotype in lineage-switched AML with KMT2A rearrangement.
Mikami T, Kato I, Nishimura A, Eguchi-Ishimae M, Kamitori T, Tasaka K, Kubota H, Isobe T, Uchihara Y, Namikawa Y, Hamada S, Tsujimoto S, Inoue S, Hamabata T, Izawa K, Miyamura T, Tomizawa D, Imamura T, Toyoda H, Eguchi M, Goto H, Ogawa S, Takagi M, Wing JB, Takita J. Mikami T, et al. Among authors: goto h. Nat Commun. 2025 Aug 26;16(1):7955. doi: 10.1038/s41467-025-63271-y. Nat Commun. 2025. PMID: 40858576 Free PMC article.
Myeloid/natural killer (NK) cell precursor acute leukemia as a distinct leukemia type.
Nishimura A, Yokoyama K, Naruto T, Yamagishi C, Imamura T, Nakazono H, Kimura S, Ito M, Sagisaka M, Tanaka Y, Piao J, Namikawa Y, Yanagimachi M, Isoda T, Kanai A, Matsui H, Isobe T, Sato-Otsubo A, Higuchi N, Takada A, Okuno H, Saito S, Karakawa S, Kobayashi S, Hasegawa D, Fujisaki H, Hasegawa D, Koike K, Koike T, Rai S, Umeda K, Sano H, Sekinaka Y, Ogawa A, Kinoshita A, Shiba N, Miki M, Kimura F, Nakayama H, Nakazawa Y, Taga T, Taki T, Adachi S, Manabe A, Koh K, Ishida Y, Takita J, Ishikawa F, Goto H, Morio T, Mizutani S, Tojo A, Takagi M. Nishimura A, et al. Among authors: goto h. Sci Adv. 2023 Dec 15;9(50):eadj4407. doi: 10.1126/sciadv.adj4407. Epub 2023 Dec 13. Sci Adv. 2023. PMID: 38091391 Free PMC article.
3,879 results